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Stent Migration: A Risk in the Treatment of Renal
Access Patients
Andrew J. Olinde1, Devin Conway1, Jay Hollman1, John
Schellack2, Paul Perkowski2, Joseph Grifﬁn1. 1Vascular
Specialty Center, Baton Rouge, La; 2Vascular Clinic,
Baton Rouge, La
Objectives: Central venous strictures often lead to
signiﬁcant arm swelling and access malformation in patients
with chronic renal failure. The purpose of this study is to
acknowledge the risk of stent migration in this subset of
patients treated for failing access grafts.
Methods: A retrospective chart review of patients
undergoing diagnostic ﬁstulagrams and percutanous inter-
vention of malfunctioning accesses was done from June
2007 to November 2012 in two major hospitals in Baton
Rouge, Louisiana. A total of 5184 ﬁstulagrams were per-
formed. 1189 (22.9%) procedures involved percutaneous
thrombectomy of the accesses. 2882 (55.6%) procedures
included balloon dilatation of the access or venous outﬂow
strictures. 796 (15.3%) patients had stents placed either in
the access or proximal central veins.
Results: Of the 796 stents placed in this series, six
migrated after deployment over varied time periods. Five
stents migrated to the heart requiring open heart surgical
removal. One patient had a stent migrate from the right
subclavian vein to the innominate vein.
Conclusions: Migration of stents can occur in the treat-
ment of failing renal access grafts. This is the largest reported
series to date in the literature of such events in renal failure
patients. The majority of stents migrated to the heart. The
high ﬂow system generated by these renal access grafts and
eventual gradual central vein dilatation in this patient popula-
tion increase the risk of future migration. Interventionalists
must be cognizant of this potential complication with the
need for selective accurate placement of stents.Despite proper
placement, stent migration may be unavoidable.
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Patients 1 2 3 4 5
BM-bare metal
CS-covered
10 mm  26 mm BM 7 mm  40 mm CS 9 mm  40 mm BM 10 mm  60 mm
BM 12 mm  60 mm BM
11 mm  100 mm
CS
Location placed Subclavian vein Proximal access graft Basilic vein Common and external
iliac veins
Subclavian vein
Migration
diagnosed
4 days Same day 3 years 6 weeks 8 months
Migration destiniation Tricuspid valve Pulmonary valve Tricuspid valve Right atrium and right ventricle Innominate vein
Treatment Open heart retrieval Open heart retrieval Postmortem retrieval Open heart retrieval Balloon dilatation
of stentPS82.
Race and Insurance Status Have Limited Effect on
Long-Term Vascular Access Outcomes in Patients at
an Inner City University Hospital
Jeffrey J. Siracuse, Adi Wollstein, Yuriy Kotsurovskyy,
Diana Catz, Irene Epelboym, In-Kyong Kim, Heather
L. Gill, Nicholas J. Morrissey. New York-Presbyterian
Hospital, Columbia University, College of Physicians
and Surgeons, New York, NY
Objectives: Insurance status and race are potential
barriers to health care maintenance. We assessed their
contribution to upper extremity vascular access outcomes
in our population.
Methods: We retrospectively reviewed outcomes of
601 vascular access patients from 2004-2012 at our institu-
tion. We recorded patient demographics, comorbidities,
and complications. Primary outcomes were reintervention,
long-term mortality, and kidney transplantation.
Results: Arteriovenous ﬁstulas (AVF) accounted for
majority (66%) of operations. Median age was 62, 58%
were male. Race, a self-reported variable, was 50%Hispanic,
22% white, and 19% black. Most had Medicare only (42%),
while 31% had private insurance and 27% had Medicaid.
Black patients were less likely to get an AVF compared to
whites and Hispanics (P < .05). White patients were signif-
icantly older than either Hispanics or blacks (68 vs 61 vs 58;
P< .05). Overall freedom from reintervention at 5 years was
55%, with infection (HR, 2.0; 95% CI, 1.3-3.0), stenosis
(HR, 3.2; 95% CI, 2.3-4.3), thrombosis (HR, 1.7; 95%
CI, 1.2-2.4), and nerve injury (HR, 4.1; 95% CI, 1.5-
11.5) being independent predictors of reintervention.
Mortality at 5 years was 35%, predicted by AV graft place-
ment (HR, 1.9; 95% CI, 1.4-2.7), low albumin (HR, 0.7;
95% CI, 0.6-0.9), white race (HR, 1.9; 95% CI, 1.3-2.8),
and not receiving a kidney transplant (HR, 0.3; 95% CI,
0.2-0.6). Transplantation rate was 31% at 5 years and pre-
dicted by high albumin (HR, 1.9; 95% CI, 1.4-2.6), AVF
(HR, 1.6; 95%, 1.1-2.6), and no CAD (HR, 0.6; 95% CI,
0.4-0.9). Race and insurance status did not affect reinterven-
tion or transplantation rate.
Conclusions: Controlling for patient and clinical
factors, insurance status did not have a signiﬁcant effect
on long term vascular access outcomes in our population.
Race was not signiﬁcantly associated with reintervention
or transplantation, however more black patients had less
suitable vasculature for AVF, and white patients had a lower
long term survival, possibly due to more advanced age.
